Your browser doesn't support javascript.
loading
ADAM17 stabilizes its interacting partner inactive Rhomboid 2 (iRhom2) but not inactive Rhomboid 1 (iRhom1).
Weskamp, Gisela; Tüshaus, Johanna; Li, Daniel; Feederle, Regina; Maretzky, Thorsten; Swendemann, Steven; Falck-Pedersen, Erik; McIlwain, David R; Mak, Tak W; Salmon, Jane E; Lichtenthaler, Stefan F; Blobel, Carl P.
Afiliación
  • Weskamp G; Arthritis and Tissue Degeneration Program, Hospital for Special Surgery, New York, New York 10021.
  • Tüshaus J; Institute for Advanced Study, Technical University Munich, 85748 Garching, Germany; Neuroproteomics, School of Medicine, Klinikum rechts der Isar, Technical University Munich, 81675 Munich, Germany; German Center for Neurodegenerative Diseases (DZNE), 81377 Munich, Germany.
  • Li D; Arthritis and Tissue Degeneration Program, Hospital for Special Surgery, New York, New York 10021.
  • Feederle R; German Center for Neurodegenerative Diseases (DZNE), 81377 Munich, Germany; Institute for Diabetes and Obesity, Monoclonal Antibody Core Facility, Helmholtz Zentrum Munich, German Research Center for Environmental Health, 85764 Neuherberg, Germany.
  • Maretzky T; Inflammation Program and Department of Internal Medicine, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa 52242.
  • Swendemann S; Arthritis and Tissue Degeneration Program, Hospital for Special Surgery, New York, New York 10021.
  • Falck-Pedersen E; Department of Biochemistry, Cellular and Molecular Biology, Weill Cornell Medicine, New York, New York 10021.
  • McIlwain DR; Baxter Laboratory in Stem Cell Biology, Department of Microbiology and Immunology, Stanford University, Stanford, California 94305.
  • Mak TW; Campbell Family Institute for Breast Cancer Research, Ontario Cancer Institute, University Health Network, Toronto, Ontario M5G 2M9, Canada.
  • Salmon JE; Autoimmunity and Inflammation Program, Hospital for Special Surgery, New York, New York 10021; Department of Medicine, Weill Cornell Medicine, New York, New York 10021.
  • Lichtenthaler SF; Institute for Advanced Study, Technical University Munich, 85748 Garching, Germany; Neuroproteomics, School of Medicine, Klinikum rechts der Isar, Technical University Munich, 81675 Munich, Germany; German Center for Neurodegenerative Diseases (DZNE), 81377 Munich, Germany; Munich Cluster for System
  • Blobel CP; Arthritis and Tissue Degeneration Program, Hospital for Special Surgery, New York, New York 10021; Institute for Advanced Study, Technical University Munich, 85748 Garching, Germany; Department of Medicine, Weill Cornell Medicine, New York, New York 10021; Department of Physiology, Biophysics and Sy
J Biol Chem ; 295(13): 4350-4358, 2020 03 27.
Article en En | MEDLINE | ID: mdl-32060096
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Proteínas Portadoras / Factor de Necrosis Tumoral alfa / Proteína ADAM17 / Proteínas de la Membrana Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: J Biol Chem Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Proteínas Portadoras / Factor de Necrosis Tumoral alfa / Proteína ADAM17 / Proteínas de la Membrana Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: J Biol Chem Año: 2020 Tipo del documento: Article